Drug Urology Oncology – Gnrh Agonist For Treating Adults With Advanced Prostate Cancer

Camcevi

Payments companies reported to CMS as associated with Camcevi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$615Kassociated payments (2023-2025)
4,009clinicians with associated payments
2companies reporting

By year

2023 $212K
2024 $178K
2025 $226K

Payments reported as associated with Camcevi, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Urology $441K
Physician Assistant $52K
Family $37K
Nurse Practitioner $27K
Hematology & Oncology $11K
Acute Care (Nurse Practitioner) $6,216

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Camcevi

These are the largest totals companies reported as associated with Camcevi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Richard David Sherman Oaks, CA Urology $53,680.05
Nilay Gandhi Woodbridge, VA Urology $50,019.28
Paul Sieber Lancaster, PA Urology $42,258.00
Scott Sellinger Tallahassee, FL Urology $39,717.84
Aaron Berger Chicago Ridge, IL Urology $32,830.31
David Bryan Chesterfield, MO Urology $23,481.48
Paul Yonover Chicago, IL Urology $19,204.88
Prithipal Sethi Sacramento, CA Urology $18,782.66
Michael White Dallas, TX Physician Assistant $12,500.66
Melanie Mcgilloway San Diego, CA Nurse Practitioner $11,890.18

Prescribed Camcevi?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.